- 作者：Jean-Philippe Ryckelynck ; ryckelynck-jp@chu-caen.fr ; Thierry Lobbedez ; Maxence Ficheux ; Cé ; cile Bonnamy ; Waë ; l El Haggan ; Patrick Henri ; Valé ; rie Chatelet ; Bé ; atrice Levaltier ; Bruno Hurault de Ligny
- 刊名：La Presse M¡§|dicale
- 出版年：2007
- 出版时间：December 2007
- 年：2007
- 卷：36
- 期：12_part_P2
- 页码：1823-1828
- 全文大小：257 K
Key points
Peritoneal dialysis, like hemodialysis, is a first-line therapy for patients with end-stage renal disease. Progress in medical devices and materials has reduced infectious complications such as peritonitis and catheter exit-site infections and thus decreased morbidity. Peritoneal dialysis fluids are increasingly biocompatible, result in fewer glucose degradation products, protect the peritoneal membrane better and thus improve tolerance. The maintenance of residual renal function, together with better comfort and no pain, help control the fluid and sodium balance.Automated peritoneal dialysis can be performed each night, either autonomously or assisted by a visiting nurse twice a day (to prepare, connect, and disconnect the machine). This treatment can thus be provided to most patients, regardless of their age.
Peritoneal dialysis is indicated principally for young people waiting for a kidney transplantation (to preserve their vascular network), elderly patients who wish to remain either at home or in an institution, and patients with cardiac insufficiency, because of the better hemodynamic tolerance.
Numerous obstacles, mainly nonmedical, still impede the development of peritoneal dialysis. Patients seen in emergencies start hemodialysis without necessarily receiving any information about peritoneal dialysis. Indeed, neither physicians nor patients receive adequate information.